Advances in adoptive T-cell therapy for metastatic melanoma
Current Research in Translational Medicine · 2023
DOI: 10.1016/j.retram.2023.103404 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Current Research in Translational Medicine, 2023. Verfasst von Aparimita Das und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Medway NHS Foundation Trust, Windmill Road, ME7 5NY, Gillingham, Kent, United Kingdom; Faculty of Allied Health Scien…. Hauptthemen laut MEDLINE: Melanoma, Immunotherapy, Adoptive, T-Lymphocytes, Skin Neoplasms. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 133 Literaturangaben.
Abstract (Originalsprache)
Adoptive T cell therapy (ACT) is a fast developing, niche area of immunotherapy (IO), which is revolutionising the therapeutic landscape of solid tumour oncology, especially metastatic melanoma (MM). Identifying tumour antigens (TAs) as potential targets, the ACT response is mediated by either Tumour Infiltrating Lymphocytes (TILs) or genetically modified T cells with specific receptors - T cell receptors (TCRs) or chimeric antigen receptors (CARs) or more prospectively, natural killer (NK) cells. Clinical trials involving ACT in MM from 2006 to present have shown promising results. Yet it is not without its drawbacks which include significant auto-immune toxicity and need for pre-conditioning lymphodepletion. Although immune-modulation is underway using various combination therapies in the hope of enhancing efficacy and reducing toxicity. Our review article explores the role of ACT in MM, including the various modalities - their safety, efficacy, risks and their development in the trial and the real world setting.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Oncology, Medway NHS Foundation Trust, Windmill Road, ME7 5NY, Gillingham, Kent, United Kingdom; Faculty of Allied Health Sciences, Chettinad Academy of Research and Education, Chennai, India.
- Department of Medical Oncology, Medway NHS Foundation Trust, Windmill Road, ME7 5NY, Gillingham, Kent, United Kingdom; Department of Medical Oncology, Barts Cancer Centre, St. Bartholomew's Hospital, Barts Health NHS Tr…
- Department of Medical Oncology, Medway NHS Foundation Trust, Windmill Road, ME7 5NY, Gillingham, Kent, United Kingdom.
- Department of Radiation Oncology, Pitié Salpêtrière University Hospital, Paris, France.
- Department of Medical Oncology, Gustave Roussy Institut, 94805, Villejuif, France.
- Department of Medical Oncology, Medway NHS Foundation Trust, Windmill Road, ME7 5NY, Gillingham, Kent, United Kingdom; Kent and Medway Medical School, University of Kent, Canterbury, United Kingdom; Faculty of Life Scie…
Zitieren
APA
Das, A., Ghose, A., Naicker, K., Sanchez, E., Chargari, C., Rassy, E., & Boussios, S. (2023). Advances in adoptive T-cell therapy for metastatic melanoma. Current Research in Translational Medicine. https://doi.org/10.1016/j.retram.2023.103404
Vancouver
Das A, Ghose A, Naicker K, Sanchez E, Chargari C, Rassy E, et al. Advances in adoptive T-cell therapy for metastatic melanoma. Current Research in Translational Medicine. 2023. doi:10.1016/j.retram.2023.103404
BibTeX
@article{Das2023,
author = {Das, Aparimita and Ghose, Aruni and Naicker, Kevin and Sanchez, Elisabet and Chargari, Cyrus and Rassy, Elie and Boussios, Stergios},
title = {Advances in adoptive T-cell therapy for metastatic melanoma},
journal = {Current Research in Translational Medicine},
year = {2023},
doi = {10.1016/j.retram.2023.103404}
}
EUVIMED